FIELD: chemistry.
SUBSTANCE: present invention relates to the technology of producing a triazolopyrimidinone derivative exhibiting tankyrase inhibition activity. Methods of producing a compound of formula I are characterized by steps consisting of eight and seven steps.
EFFECT: providing effective methods for obtaining an end product with high purity and high output.
10 cl, 2 ex
| Title | Year | Author | Number |
|---|---|---|---|
| PYRIMIDINE DERIVATIVE THAT SUPPRESSES CANCER CELL GROWTH AND MEDICAL APPLICATION THEREOF | 2020 |
|
RU2792849C1 |
| METHOD OF PRODUCING A PYRROLOPYRIDINE DERIVATIVE | 2021 |
|
RU2830589C1 |
| COMPOUND HAVING AGONISTIC ACTIVITY AGAINST GPR119, METHOD FOR ITS PREPARATION, AND PHARMACEUTICAL COMPOSITION CONTAINING IT AS AN EFFECTIVE COMPONENT | 2015 |
|
RU2670197C1 |
| INHIBITORS OF FIBROBLAST GROWTH FACTOR RECEPTOR | 2013 |
|
RU2679130C2 |
| HETEROCYCLIC COMPOUNDS, METHOD FOR PRODUCTION THEREOF AND USE THEREOF | 2015 |
|
RU2667498C2 |
| PYRIMIDINE- AND NITROGEN-CONTAINING BICYCLIC COMPOUND | 2020 |
|
RU2827867C1 |
| COMPOUNDS OF FORMULA (I) AND FORMULA (A), PHARMACEUTICAL COMPOSITION, MEDICINAL PRODUCT, USE AND METHOD OF OBTAINING COMPOUNDS OF FORMULA (I) | 2018 |
|
RU2822758C2 |
| NOVEL PIPERIDINE DERIVATIVE AND PHARMACEUTICAL COMPOSITION FOR INHIBITING AUTOTAXIN | 2022 |
|
RU2834850C2 |
| NOVEL COMPOUNDS AS HISTONE DEACETYLASE 6 INHIBITOR AND PHARMACEUTICAL COMPOSITION CONTAINING THEM | 2021 |
|
RU2814288C1 |
| PYRIDINO[1,2-A]PYRIMIDONE ANALOGUE USED AS AN MTOR/PI3K INHIBITOR | 2015 |
|
RU2658912C1 |
